Huntingtin-associated protein-1 is a modifier of the age-at-onset of Huntington's disease
- PMID: 18192679
- DOI: 10.1093/hmg/ddn003
Huntingtin-associated protein-1 is a modifier of the age-at-onset of Huntington's disease
Abstract
A polyglutamine repeat expansion of more than 36 units in a protein called huntingtin (htt) is the only known cause of Huntington's disease (HD). The expanded repeat length is inversely correlated with the age-at-onset (AAO), however, the onset age among HD patients with CAG repeats below 60 units varies considerably. In addition to environmental factors, genetic factors different from the expanded CAG repeat length can modify the AAO of HD. We hypothezised that htt interacting proteins might contribute to this variation in the AAO and investigated human htt-associated protein-1 (HAP1) using genetic and functional assays. We identified six polymorphisms in the HAP1 gene including one that substitutes methionine (M441) for threonine (T441) at amino acid 441. Analyzing 980 European HD patients, we found that patients homozygous for the M441 genotype show an 8-year delay in the AAO. Functional assays demonstrated that human M441-HAP1 interacts with mutant htt more tightly than does human T441-HAP1, reduces soluble htt degraded products and protects against htt-mediated toxicity. We thus provide genetic and functional evidence that the M441-HAP1 polymorphism modifies the AAO of HD.
Similar articles
-
Age at onset in Huntington's disease: replication study on the association of HAP1.Parkinsonism Relat Disord. 2012 Nov;18(9):1027-8. doi: 10.1016/j.parkreldis.2012.05.020. Epub 2012 Jun 12. Parkinsonism Relat Disord. 2012. PMID: 22698993
-
The S18Y polymorphism in the UCHL1 gene is a genetic modifier in Huntington's disease.Neurogenetics. 2006 Mar;7(1):27-30. doi: 10.1007/s10048-005-0023-z. Epub 2005 Dec 21. Neurogenetics. 2006. PMID: 16369839
-
Age at onset in Huntington's disease is modified by the autophagy pathway: implication of the V471A polymorphism in Atg7.Hum Genet. 2010 Oct;128(4):453-9. doi: 10.1007/s00439-010-0873-9. Epub 2010 Aug 10. Hum Genet. 2010. PMID: 20697744
-
Multiple clinical features of Huntington's disease correlate with mutant HTT gene CAG repeat lengths and neurodegeneration.J Neurol. 2019 Mar;266(3):551-564. doi: 10.1007/s00415-018-8940-6. Epub 2018 Jun 28. J Neurol. 2019. PMID: 29956026 Review.
-
Interrupting sequence variants and age of onset in Huntington's disease: clinical implications and emerging therapies.Lancet Neurol. 2020 Nov;19(11):930-939. doi: 10.1016/S1474-4422(20)30343-4. Lancet Neurol. 2020. PMID: 33098802 Review.
Cited by
-
Integration of β-catenin, sirtuin, and FOXO signaling protects from mutant huntingtin toxicity.J Neurosci. 2012 Sep 5;32(36):12630-40. doi: 10.1523/JNEUROSCI.0277-12.2012. J Neurosci. 2012. PMID: 22956852 Free PMC article.
-
Huntingtin-associated protein 1 regulates exocytosis, vesicle docking, readily releasable pool size and fusion pore stability in mouse chromaffin cells.J Physiol. 2014 Apr 1;592(7):1505-18. doi: 10.1113/jphysiol.2013.268342. Epub 2013 Dec 23. J Physiol. 2014. PMID: 24366265 Free PMC article.
-
Huntington's Disease: Relationship Between Phenotype and Genotype.Mol Neurobiol. 2017 Jan;54(1):342-348. doi: 10.1007/s12035-015-9662-8. Epub 2016 Jan 7. Mol Neurobiol. 2017. PMID: 26742514 Review.
-
The Joubert syndrome-associated missense mutation (V443D) in the Abelson-helper integration site 1 (AHI1) protein alters its localization and protein-protein interactions.J Biol Chem. 2013 May 10;288(19):13676-94. doi: 10.1074/jbc.M112.420786. Epub 2013 Mar 26. J Biol Chem. 2013. PMID: 23532844 Free PMC article.
-
Age at onset in Huntington's disease: replication study on the associations of ADORA2A, HAP1 and OGG1.Neurogenetics. 2010 Oct;11(4):435-9. doi: 10.1007/s10048-010-0248-3. Epub 2010 May 30. Neurogenetics. 2010. PMID: 20512606
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous